Christa E. Müller
Christa E. Müller
Verified email at - Homepage
TitleCited byYear
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update
BB Fredholm, AP IJzerman, KA Jacobson, J Linden, CE Müller
Pharmacological reviews 63 (1), 1-34, 2011
Recent developments in adenosine receptor ligands and their potential as novel drugs
CE Müller, KA Jacobson
Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1290-1308, 2011
Structure of the human P2Y 12 receptor in complex with an antithrombotic drug
K Zhang, J Zhang, ZG Gao, D Zhang, L Zhu, GW Han, SM Moss, ...
Nature 509 (7498), 115-118, 2014
Striatal Adenosine A2A and Cannabinoid CB1 Receptors Form Functional Heteromeric Complexes that Mediate the Motor Effects of Cannabinoids
P Carriba, O Ortiz, K Patkar, Z Justinova, J Stroik, A Themann, C Müller, ...
Neuropsychopharmacology 32 (11), 2249, 2007
Agonist-bound structure of the human P2Y12 receptor
J Zhang, K Zhang, ZG Gao, S Paoletta, D Zhang, GW Han, T Li, L Ma, ...
Nature 509 (7498), 119-122, 2014
Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors
T Gnad, S Scheibler, I Von Kügelgen, C Scheele, A Kilić, A Glöde, ...
Nature 516 (7531), 395-399, 2014
Involvement of adenosine A 1 and A 2A receptors in the motor effects of caffeine after its acute and chronic administration
M Karcz-Kubicha, K Antoniou, A Terasmaa, D Quarta, M Solinas, ...
Neuropsychopharmacology 28 (7), 1281-1291, 2003
Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A2A-selective adenosine receptor antagonists
R Sauer, J Maurinsh, U Reith, F Fülle, KN Klotz, CE Müller
Journal of medicinal chemistry 43 (3), 440-448, 2000
D Köhler, T Eckle, M Faigle, A Grenz, M Mittelbronn, S Laucher, ML Hart, ...
Circulation 116 (16), 1784-1794, 2007
CD39/ENTPD1 expression by CD4+ Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice
X Sun, Y Wu, W Gao, K Enjyoji, E Csizmadia, CE Müller, T Murakami, ...
Gastroenterology 139 (3), 1030-1040, 2010
Lignans Isolated from Valerian:  Identification and Characterization of a New Olivil Derivative with Partial Agonistic Activity at A1 Adenosine Receptors
B Schumacher, S Scholle, J Hölzl, N Khudeir, S Hess, CE Müller
Journal of Natural Products 65 (10), 1479-1485, 2002
Prodrug approaches for enhancing the bioavailability of drugs with low solubility
CE Mueller
Chemistry & Biodiversity 6 (11), 2071-2083, 2009
Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)
A Pick, H Müller, R Mayer, B Haenisch, IK Pajeva, M Weigt, H Bönisch, ...
Bioorganic & medicinal chemistry 19 (6), 2090-2102, 2011
Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor
ZG Gao, A Chen, D Barak, SK Kim, CE Müller, KA Jacobson
Journal of Biological Chemistry 277 (21), 19056-19063, 2002
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
MT Armentero, A Pinna, S Ferré, JL Lanciego, CE Müller, R Franco
Pharmacology & therapeutics 132 (3), 280-299, 2011
Adenosine receptors and their modulators
CE Müller, T Scior
Pharmaceutica Acta Helvetiae 68 (2), 77-111, 1993
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis
D Marcellino, P Carriba, M Filip, A Borgkvist, M Frankowska, I Bellido, ...
Neuropharmacology 54 (5), 815-823, 2008
Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors
CE Müller, J Iqbal, Y Baqi, H Zimmermann, A Röllich, H Stephan
Bioorganic & medicinal chemistry letters 16 (23), 5943-5947, 2006
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury
A Grenz, H Zhang, M Hermes, T Eckle, K Klingel, DY Huang, CE Müller, ...
The FASEB Journal 21 (11), 2863-2873, 2007
Adenosine receptor agonists: from basic medicinal chemistry to clinical development
L Yan, JC Burbiel, A Maaß, CE Müller
Expert opinion on emerging drugs 8 (2), 537-576, 2003
The system can't perform the operation now. Try again later.
Articles 1–20